Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Am J Obstet Gynecol. 1998 May;178(5):1054-8.

Experience with oral methylprednisolone in the treatment of refractory hyperemesis gravidarum.

Author information

  • 1Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles, USA.

Abstract

OBJECTIVE:

Our purpose was to describe the effect of oral methylprednisolone on the course of refractory hyperemesis gravidarum.

STUDY DESIGN:

Patients with intractable hyperemesis gravidarum were candidates for oral methylprednisolone. Forty-eight milligrams per day was given for 3 days followed by a tapering dose over 2 weeks. If vomiting recurred after 2 weeks of therapy or during tapering, the medication was restarted or extended but not longer than 1 month total.

RESULTS:

Seventeen of 18 patients (94%) were free of vomiting and were able to tolerate a regular diet within 3 days. Seven did not have further symptoms during their pregnancies. Nine vomited during or after tapering, but 7 of these responded to extension or reinstitution of therapy. Four of 6 patients on total parenteral nutrition at the start of therapy had a complete response within 3 days.

CONCLUSIONS:

A short course of oral methylprednisolone appears to be a reasonable therapeutic alternative for intractable hyperemesis.

PMID:
9609583
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk